Divisas / NUVB
NUVB: Nuvation Bio Inc Class A
2.55
USD
0.17
(7.14%)
El tipo de cambio de NUVB de hoy ha cambiado un 7.14%. En este caso, el precio mínimo en el mercado ha alcanzado 2.36, mientras que el máximo ha alcanzado 2.57.
Siga la dinámica de la pareja de divisas Nuvation Bio Inc Class A. El gráfico histórico le mostrará cómo ha cambiado el precio de %AssetName% en el pasado. Alternando entre diferentes marcos temporales, podrá monitorear las tendencias y la dinámica del tipo de cambio por minutos, horas, días, semanas y meses. Use esta información para predecir los cambios en el mercado y tomar decisiones comerciales fundamentadas.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
NUVB News
- TipRanks 3 ‘Strong Buy’ Russell 2000 Stocks with Triple-Digit Upside Potential - TipRanks.com
- Investing Nuvation Bio stock rating reiterated at Market Outperform by Citizens JMP
- Investing Nuvation Bio Announces National Comprehensive Cancer Network ® Adds Taletrectinib (IBTROZI™) as Preferred Option to Clinical Practice Guidelines in Oncology for Advanced ROS1+ Non-Small Cell Lung Ca
- Seeking Alpha Nuvation Bio - A Justified Fall Based On Post Marketing Requirements (NYSE:NUVB)
- Investing Nuvation Bio price target lowered to $6 from $10 at RBC Capital
- GuruFocus Big Pharma's $18.3B Secret: Why U.S. Drug Giants Are Flooding China With Licensing Deals
- Reuters US pharma bets big on China to snap up potential blockbuster drugs
- Investing Nuvation Bio stock holds steady as FDA approves lung cancer drug
- Investing Nuvation Bio price target maintained at $6 by Citizens JMP
- Investing Nuvation Bio stock falls after FDA approves lung cancer drug
- Investing # FDA approves Nuvation Bio’s lung cancer drug taletrectinib
- Seeking Alpha Nuvation Bio: Judgement Day Grows Closer (NYSE:NUVB)
- Investing JMP maintains $6 target on Nuvation Bio stock ahead of PDUFA
- Investing Citizens JMP highlights key ASCO presentations
- Investing Nuvation Bio To Present New Data from Pivotal Clinical Studies of Taletrectinib in Advanced ROS1-Positive Non-Small Cell Lung Cancer at ASCO 2025 Annual Meeting
Rango diario
2.36
2.57
Rango anual
1.54
3.83
- Cierres anteriores
- 2.36
- Open
- 2.38
- Bid
- 2.55
- Ask
- 2.85
- Low
- 2.36
- High
- 2.57
- Volumen
- 5.835 K
- Cambio diario
- 7.14%
- Cambio mensual
- 30.77%
- Cambio a 6 meses
- 11.84%
- Cambio anual
- -33.42%
24 julio, jueves
12:30
USD
- Act.
- Pronós.
- -0.12
- Prev.
- -0.28
12:30
USD
- Act.
- Pronós.
- 215 K
- Prev.
- 221 K
12:30
USD
- Act.
- Pronós.
- 1.972 M
- Prev.
- 1.956 M
12:30
USD
- Act.
- Pronós.
- 225.813 K
- Prev.
- 229.500 K
14:00
USD
- Act.
- Pronós.
- 0.684 M
- Prev.
- 0.623 M
14:00
USD
- Act.
- Pronós.
- -3.2%
- Prev.
- -13.7%
14:30
USD
- Act.
- Pronós.
- 20 B
- Prev.
- 46 B
15:00
USD
- Act.
- Pronós.
- -2
- Prev.
- -2
15:00
USD
- Act.
- Pronós.
- -5
- Prev.
- 5
15:30
USD
- Act.
- Pronós.
- Prev.
- 4.230%
15:30
USD
- Act.
- Pronós.
- Prev.
- 4.270%
17:00
USD
- Act.
- Pronós.
- Prev.
- 2.220%